News

In March 20, 2018, GlycoT was awarded a Phase I SBIR grant (R43GM128547) from the National Institute of General Medical Sciences (NIGMS) to develop a 13C-labeled IgG-Fc glycopeptide library using our technology platform, which could be applied as standards for absolute quantification of antibody glycosylation from recombinant antibodies and clinical samples for quality control of biologics manufacturing, and/or for diagnosis and biomarker discovery